Insmed, Inc (INSM) Launches National Awareness Campaign
Insmed, Inc (INSM), a leading developer of biopharmaceuticals, announced that the company has launched a broad educational campaign. This educational campaign is focused on the importance of establishing a regulatory pathway in the U.S. for large molecule protein-based drugs. Insmed has launched a number of public initiatives to promote the awareness of such a need. If Congress is to establish a separate pathway for the approval of FOBs, access to drugs would increase and the costs for each prescription would decrease. Currently, Europe has a specific scientific, regulatory, and legal framework for the approval of small-molecule generic drugs. However, no…